Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibiotics
antibiotics
FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer
Forbes
Sat, 11/16/19 - 10:34 pm
superbugs
antibiotics
antibiotic resistance
Talicia
FDA
stomach bug
Helicobecter pylori
Redhill Biopharma
After positive panel vote, Shionogi antibiotic scores US approval
Endpoints
Fri, 11/15/19 - 10:50 am
Shionogi
antibiotics
FDA
cUTI
UTIs
Fetroja
CDC report: 35,000 Americans die of antibiotic-resistant infections each year
Stat
Wed, 11/13/19 - 11:27 pm
CDC
antibiotics
antibiotic resistance
As resistance to standard antibiotics grows, RedHill's H. pylori regimen secures FDA approval
Endpoints
Mon, 11/4/19 - 10:22 am
WHO
H pylori
Redhill Biopharma
antibiotics
antibiotic resistance
rifabutin
FDA
Why Scott Gottlieb, venture capitalist, sees opportunity in antibiotics
Endpoints
Wed, 10/30/19 - 10:05 am
Scott Gottlieb
FDA
antibiotics
drug development
GlaxoSmithKline kick-starts first-of-its-kind late-stage antibiotic test
Fierce Biotech
Mon, 10/28/19 - 10:55 am
GSK
antibiotics
antibiotic resistance
gepotidacin
Researchers Estimate Costs of Exclusivity Extensions to Encourage Antibiotic Development
RAPS.org
Mon, 10/21/19 - 06:04 pm
legistlation
regulatory
exclusivity
antibiotics
Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote
Endpoints
Thu, 10/17/19 - 10:28 am
Shionogi
FDA
advisory panels
antibiotics
cefiderocol
UTIs
In-house FDA review flags a suspicious imbalance in deaths as Shionogi hunts an OK for antibiotic
Endpoints
Mon, 10/14/19 - 10:26 am
Shionogi
FDA
advisory panels
antibiotics
UTIs
cefiderocol
Still too little progress on antibiotic resistance, says O’Neill report update
Pharmaforum
Fri, 10/11/19 - 10:33 am
antibiotics
antibiotic resistance
drug development
Shionogi celebrates antibiotic win in pneumonia just ahead of its date with FDA regulators
Endpoints
Wed, 10/9/19 - 10:39 am
Shionogi
antibiotics
FDA
cefiderocol
nosocomial pneumonia
MGB tops up cash pool to wrap up antibiotic phase 2a
Fierce Biotech
Fri, 08/30/19 - 10:29 am
MGB Biopharma
antibiotics
MGB-BP-3
C. difficile
clinical trials
Nabriva gets first approval in novel antibiotic class
BioCentury
Mon, 08/19/19 - 11:34 pm
Nabriva
antibiotics
Xenleta
lefamulin
community-acquired bacterial pneumonia
Ahead of FDA decisions on one antibiotic, Nabriva plans resubmission of another
BioCentury
Fri, 08/16/19 - 11:59 pm
Nabriva Therapeutics
antibiotics
lefmulin
CMS prescribes payment fix to resuscitate US antibiotic industry
Endpoints
Mon, 08/5/19 - 11:11 am
CMS
antibiotics
drug development
Why Merck is in infectious disease for the long haul
BioCentury
Mon, 07/15/19 - 10:50 pm
Merck
R&D
infectious diseases
antibiotics
U.K. launches subscription model to pay for antibiotics
BioCentury
Wed, 07/10/19 - 10:20 am
UK
antibiotics
subscription model
In starved antibiotic field, Melinta soars as FDA grants speedy drug review
Endpoints
Thu, 06/20/19 - 09:53 am
Melinta Therapeutics
antibiotics
Baxdela
community-acquired bacterial pneumonia
FDA
priority review
Once picked as a $500M winner, bankrupt Achaogen auctions off its antibiotic for a fraction of that
Endpoints
Fri, 06/7/19 - 12:01 pm
Achaogen
antibiotics
Zemdri
New antibiotic treatments focus of reintroduced Senate bill
BioCentury
Thu, 06/6/19 - 10:09 pm
antibiotics
Senate
antibiotic resistance
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »